BioSpace News Archive

Achilles Therapeutics plc today announced that United States (US) patent 11,504,398 has been granted.

Ventyx Biosciences, Inc. today announced that Company executives will provide a company overview during fireside chats at the following upcoming investor conferences.

PMV Pharmaceuticals, Inc. (Nasdaq: PMVP; “PMV Pharma”) today announced that David H. Mack, Ph.D., President & Chief Executive Officer of PMV Pharmaceuticals, will participate in a virtual fireside chat at the 5th Annual Evercore ISI HealthCONx Conference, taking place November 29 – December 1, 2022.

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference being held in New York, NY from November 29 to December 1, 2022.

Keros Therapeutics, Inc. today announced that Keros’ President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in fireside chat presentations at the Piper Sandler 34th Annual Healthcare Conference and the 5th Annual Evercore ISI HealthCONx Conference.

Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero) today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will participate in a fireside chat and be available for one-on-one meetings at the 5th Annual Evercore ISI HealthCONx Conference.

Cue Biopharma, Inc. announced that it will take part in two fireside chats, the first at the Piper Sandler 34th Annual Healthcare Conference, to be held November 29-December 1 in New York, and the second at the JMP Securities Hematology & Oncology Summit, to be held virtually December 6-7.

Icosavax, Inc. (Nasdaq: ICVX) today announced that the company will participate in and host one-on-one meetings at the 5th Annual Evercore ISI HealthCONx Conference taking place November 29 through December 1, 2022.

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) today announced that Jerry Durso, President and Chief Executive Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will participate in a fireside chat at Piper Sandler’s 34th Annual Healthcare Conference, taking place in person on Thursday, December 1, 2022.

PaxMedica, Inc. (Nasdaq: PXMD) today announced it will be presenting at the Benchmark Company’s 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1st, 2022 at the New York Athletic Club in New York City.